High-performance liquid chromatographic assay for vigabatrin and its primary degradation product in a pharmaceutical tablet formulation
- 31 December 1987
- journal article
- research article
- Published by Elsevier in Journal of Chromatography A
- Vol. 398, 351-354
- https://doi.org/10.1016/s0021-9673(01)96525-2
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Quantitative analysis of vigabatrin in plasma and urine by reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1985
- Biochemical and clinical effects of γ‐vinyl GABA in patients with epilepsyNeurology, 1984
- DOUBLE-BLIND STUDY OF γ-VINYL GABA IN PATIENTS WITH REFRACTORY EPILEPSYThe Lancet, 1984
- The perspective of GABA replenishment therapy in the epilepsies: A critical evaluation of hopes and concernsLife Sciences, 1983
- Gamma-vinyl-GABA: A single-blind trial in patients with epilepsyActa Neurologica Scandinavica, 1983
- Determination of the R(−)- and S(+)-enantiomers of γ-vinyl-γ-aminobutyric acid in human body fluids by gas chromatography—mass spectrometryJournal of Chromatography B: Biomedical Sciences and Applications, 1983
- γ-AMINOBUTYRIC-ACID DEFICIENCY IN BRAIN OF SCHIZOPHRENIC PATIENTSThe Lancet, 1979
- HUNTINGTON'S CHOREABrain, 1974
- Glutamic acid decarboxylase in Parkinson's disease and epilepsyNeurology, 1971